A survey of some risk factors for atrial fibrillation in patients with arrhythmia at Cho Ray Hospital
Main Article Content
Abstract
Background: Atrial fibrillation (AF) is a common arrhythmia with serious complications. Identifying its risk factors is crucial for prevention and treatment. This study aimed to identify independent risk factors for AF in arrhythmia patients at Cho Ray Hospital. Methods: This descriptive cross-sectional study included 272 patients treated for arrhythmia between December 2023 and May 2024. Data on clinical history and paraclinical indicators were collected. The prevalence of AF was determined, and both univariate and multivariate logistic regression analyses were used to investigate the association between potential risk factors and AF. Statistical significance was set at a P-value <0.05. Results: The study found an AF prevalence of 14.7% in the patient group. Univariate analysis showed that age, heart failure, left atrial (LA) dimension, and estimated glomerular filtration rate (eGFR) were significantly associated with AF. However, a multivariate model identified only LA dimension and a history of diabetes as independent risk factors. For every one-millimeter increase in LA dimension, the risk of AF increased by 19.8% (OR=1.198, 95% CI: 1.093-1.313). Diabetic patients had a 3.4-fold higher risk of AF compared to non-diabetic individuals (OR=3.421, 95% CI: 1.021-11.466). Conclusion: The findings suggest that an enlarged LA and a history of diabetes are independent risk factors for AF in this patient population. These results provide an important basis for early screening and management to improve outcomes for arrhythmia patients
Article Details
References
2. Costabel, J.P., L.M. Burgos, and M. Trivi, The Significance Of Troponin Elevation In Atrial Fibrillation. J Atr Fibrillation, 2017. 9(6): p. 1530.
3. Diseases, G.B.D. and C. Injuries, Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020. 396(10258): p. 1204-1222.
4. Hindricks, G., et al., 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J, 2021. 42(5): p. 373-498.
5. Schnabel, R.B., et al., 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet, 2015. 386(9989): p. 154-62.
6. Smith, J.G., et al., Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol, 2010. 56(21): p. 1712-9.
7. Society, H.R., Guide to Atrial Fibrillation. 2014: USA.
8. Tsao, C.W., et al., Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation, 2022. 145(8): p. e153-e639.